215 related articles for article (PubMed ID: 17659605)
1. Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children.
Pedersen S; Agertoft L; Williams-Herman D; Kuznetsova O; Reiss TF; Knorr B; Dass SB; Wolthers OD
Pediatr Pulmonol; 2007 Sep; 42(9):838-43. PubMed ID: 17659605
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
Buchvald F; Bisgaard H
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):309-13. PubMed ID: 14533665
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of lower leg and height growth in children with asthma treated with inhaled budesonide from a new dry powder inhaler.
Gradman J; Wolthers OD
Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e206-12. PubMed ID: 19298635
[TBL] [Abstract][Full Text] [Related]
5. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
Kumar V; Ramesh P; Lodha R; Pandey RM; Kabra SK
J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754
[TBL] [Abstract][Full Text] [Related]
6. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
Becker A; Swern A; Tozzi CA; Yu Q; Reiss T; Knorr B
Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699
[TBL] [Abstract][Full Text] [Related]
7. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
Zeiger RS; Bird SR; Kaplan MS; Schatz M; Pearlman DS; Orav EJ; Hustad CM; Edelman JM
Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
[TBL] [Abstract][Full Text] [Related]
8. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
10. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
Szefler SJ; Carlsson LG; Uryniak T; Baker JW
J Allergy Clin Immunol Pract; 2013 Jan; 1(1):58-64. PubMed ID: 24229823
[TBL] [Abstract][Full Text] [Related]
11. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
[TBL] [Abstract][Full Text] [Related]
12. Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study.
Becker AB; Kuznetsova O; Vermeulen J; Soto-Quiros ME; Young B; Reiss TF; Dass SB; Knorr BA;
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):800-7. PubMed ID: 16802767
[TBL] [Abstract][Full Text] [Related]
13. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
Leigh R; Vethanayagam D; Yoshida M; Watson RM; Rerecich T; Inman MD; O'Byrne PM
Am J Respir Crit Care Med; 2002 Nov; 166(9):1212-7. PubMed ID: 12403690
[TBL] [Abstract][Full Text] [Related]
14. Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction.
Vidal C; Fernández-Ovide E; Piñeiro J; Nuñez R; González-Quintela A
Ann Allergy Asthma Immunol; 2001 Jun; 86(6):655-8. PubMed ID: 11428738
[TBL] [Abstract][Full Text] [Related]
15. The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma.
Davies GM; Dasbach EJ; Santanello NC; Knorr BA; Bratton DL
Clin Ther; 2004 Nov; 26(11):1895-904. PubMed ID: 15639701
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; De Lorenzo A
Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
[TBL] [Abstract][Full Text] [Related]
17. Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial.
Chen YZ; Busse WW; Pedersen S; Tan W; Lamm CJ; O'Byrne PM
Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():7-13. PubMed ID: 16573703
[TBL] [Abstract][Full Text] [Related]
18. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
Miraglia del Giudice M; Piacentini GL; Capasso M; Capristo C; Maiello N; Boner AL; Capristo AF
Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
[TBL] [Abstract][Full Text] [Related]
19. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.
Simons FE; Villa JR; Lee BW; Teper AM; Lyttle B; Aristizabal G; Laessig W; Schuster A; Perez-Frias J; Sekerel BE; Menten J; Leff JA
J Pediatr; 2001 May; 138(5):694-8. PubMed ID: 11343045
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, randomised, controlled trial assessing controller medications in asthma.
Shah AR; Sharples LD; Solanki RN; Shah KV
Respiration; 2006; 73(4):449-56. PubMed ID: 16407639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
